THE QUEST: SEEKING AN ULTIMATE CURE
Page: 5 of 5 View All
How Penn researcher is taking on blindness
Gene therapy on mice has been promising. Human trials are next. The target: retinitis pigmentosa.
And scientists at the University of Iowa, which has the largest RP screening laboratory in the world, were asked to start looking for PDE patients.
Finally, everything was in place. The first of the animal studies started last month. And the list of PDE patients has grown to 12.
